Technology

Ascendis Pharma

$158.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (+0.22%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ASND and other stocks, options, and ETFs commission-free!

About ASND

Ascendis Pharma A/S American Depositary Shares, also called Ascendis Pharma, is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark. The listed name for ASND is Ascendis Pharma A/S American Depositary Shares.

CEO
Jan Møller Mikkelsen
Employees
—
Headquarters
Hellerup, Capital Region
Founded
2006
Market Cap
8.86B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
137.63K
High Today
$163.54
Low Today
$157.41
Open Price
$161.77
Volume
216.38K
52 Week High
$183.98
52 Week Low
$92.00

Collections

ASND Earnings

-$2.70
-$1.80
-$0.90
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, After Hours

You May Also Like

AMBC+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure